BD (Becton, Dickinson and Company)
Medical technology company that serves healthcare institutions, life science researchers, clinical laboratories and the industry.
Launch date
Employees
Market cap
AUD105.2b
Enterprise valuation
AUD126.9b (Public information from Sep 2024)
Share price
$231.59 BDX
Franklin Lakes New Jersey (HQ)
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Revenues | 17.3b | 17.1b | 20.2b | 18.9b | 19.4b | 20.1b | 21.4b |
% growth | 8 % | (1 %) | 18 % | (7 %) | 3 % | 4 % | 6 % |
EBITDA | 4.1b | 4.0b | 5.2b | 4.6b | 4.7b | - | - |
% EBITDA margin | 24 % | 23 % | 26 % | 24 % | 24 % | - | - |
Profit | 1.2b | 874m | 2.1b | 1.8b | 1.5b | - | - |
% profit margin | 7 % | 5 % | 10 % | 9 % | 8 % | - | - |
R&D budget | 1.1b | 1.1b | 1.3b | 1.3b | 1.2b | - | - |
R&D % of revenue | 6 % | 6 % | 7 % | 7 % | 6 % | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | IPO | |
* | $2.2m | Post IPO Equity | |
Total Funding | - |
Related Content
Recent News about BD (Becton, Dickinson and Company)
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
Investments by BD (Becton, Dickinson and Company)
EditACQUISITION by BD (Becton, Dickinson and Company) Oct 2014
ACQUISITION by BD (Becton, Dickinson and Company) Jul 2011
ACQUISITION by BD (Becton, Dickinson and Company) Jul 2021
ACQUISITION by BD (Becton, Dickinson and Company) Oct 2014
ACQUISITION by BD (Becton, Dickinson and Company) Jun 2022
ACQUISITION by BD (Becton, Dickinson and Company) Dec 2021
ACQUISITION by BD (Becton, Dickinson and Company) Feb 2012
ACQUISITION by BD (Becton, Dickinson and Company) Feb 2022